# Individualized DTI-ALPS Identifies Phase-Specific Glymphatic Dysfunction in Early-Stage Bipolar Disorder

**Authors:** Xiaoxi Zhao, Mingli Li, Qiang Wang, Lihong Deng, Liansheng Zhao, Hua Yu, Xiaojing Li, Wei Deng, Wanjun Guo, Tao Li, Wei Wei

PMC · DOI: 10.3390/biomedicines14030699 · Biomedicines · 2026-03-17

## TL;DR

A new method called iALPS reveals subtle glymphatic system changes in young people with bipolar disorder during depressive episodes.

## Contribution

The study introduces an individualized DTI-ALPS pipeline that detects phase-specific glymphatic dysfunction in early-stage bipolar disorder.

## Key findings

- The iALPS pipeline detected a trend-level reduction in ALPS index in BD patients during depressive episodes.
- Conventional cFSL pipeline found no group differences in glymphatic function.
- Glymphatic dysfunction in BD appears to be phase-specific rather than a constant trait.

## Abstract

Background: The glymphatic system, essential for brain waste clearance and neuroimmune regulation, remains underexplored in the context of bipolar disorder (BD) among young populations. Methods: Using diffusion tensor image analysis along the perivascular space (DTI-ALPS), we compared ALPS indices derived from the conventional FSL-based (cFSL) pipeline with those from the individualized ALPS (iALPS) pipeline. A cohort of young adults comprising 77 individuals with BD and 289 healthy controls was analyzed to evaluate methodological consistency and to identify disorder-specific alterations in glymphatic function. Results: The two pipelines showed only moderate agreement (Lin’s concordance correlation coefficient = 0.52–0.60), suggesting that differences in ROI placement strategies significantly affect ALPS estimation. While the cFSL pipeline detected no group differences, the iALPS pipeline identified a trend-level reduction in ALPS index in patients with BD during depressive episodes, particularly in the right hemisphere (p = 0.036, uncorrected, FDR-adjusted p = 0.071). No significant glymphatic alterations were observed in individuals with early-stage BD. Conclusions: These findings suggest that glymphatic dysfunction in psychiatric disorders may be phase-specific on illness. The use of individualized and automated analytical strategies, such as the iALPS pipeline, appears to enhance sensitivity to subtle, state-related brain changes that conventional methods may overlook. This methodological advancement provides a more biologically informed framework for future large-scale and longitudinal studies aimed at elucidating the role of glymphatic function in the pathophysiology of psychiatric disorders.

## Linked entities

- **Diseases:** bipolar disorder (MONDO:0004985)

## Full-text entities

- **Diseases:** BD (MESH:D001714), ALPS (MESH:D056735), psychiatric disorders (MESH:D001523), depressive (MESH:D003866), Glymphatic Dysfunction (MESH:D006331)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13024597/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024597/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC13024597/full.md

---
Source: https://tomesphere.com/paper/PMC13024597